Related Experiment Video
Updated: Sep 23, 2025

04:32
A Uniform Shear Assay for Human Platelet and Cell Surface Receptors via Cone-plate Viscometry
Published on: June 5, 2019
7.8K
GPVI expression is linked to platelet size, age, and reactivity
Alicia Veninga1, Stefan Handtke2, Konstanze Aurich2
1Department of Biochemistry, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University, Maastricht, The Netherlands.
Blood Advances
|May 13, 2022
Summary
Large platelets, particularly younger ones with high glycoprotein VI (GPVI) expression, show greater reactivity and form larger thrombi. This highlights GPVI
Area of Science:
- Hematology
- Cell Biology
- Biochemistry
Background:
- Platelets exhibit significant intraindividual heterogeneity in size, age, and receptor expression, impacting their reactivity.
- Understanding the combined influence of these factors is crucial for comprehending platelet function in hemostasis and thrombosis.
Purpose of the Study:
- To investigate the contribution of platelet size, age, and surface receptor levels to platelet reactivity.
- To characterize highly reactive platelet subpopulations and their signaling pathways.
Main Methods:
- Differential centrifugation to isolate large and small platelet fractions from healthy donors.
- Flow perfusions over collagen to assess thrombus formation.
- Multicolor flow cytometry, RNA and HLA-I labeling for platelet characterization and age determination.
- Analysis of Akt phosphorylation for signal transduction.
Main Results:
- Large platelets adhered faster and formed larger thrombi compared to small platelets.
- A juvenile platelet subpopulation within large platelets showed high glycoprotein VI (GPVI) expression, correlating with increased reactivity.
- Differences in Akt phosphorylation were more pronounced between juvenile and older platelets than between large and small platelets.
- GPVI expression and reactivity decreased during storage, with better preservation at 4°C compared to 22°C.
- Elevated GPVI expression was observed in platelets from patients with immune thrombocytopenia.
Conclusions:
- High GPVI expression is a marker of highly reactive juvenile platelets, primarily found in the large platelet fraction.
- This explains the superior performance of large platelets in thrombus formation.
- Findings are relevant for studies on thrombus formation, platelet storage, and immune thrombocytopenia.
Related Concept Videos
Structure and Function of Platelets
1.6K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.6K
Formation of the Platelet Plug
7.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
7.2K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
659
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
659

